High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates from a Hospital in Central Italy | Zendy

Gianluca Morroni | Zendy; Andrea Brenciani | Zendy; Lucia Brescini | Zendy; Simona Fioriti | Zendy; Serena Simoni | Zendy; Antonella Pocognoli | Zendy; Marina Mingoia | Zendy; Eleonora Giovanetti | Zendy; Francesco Barchiesi | Zendy; Andrea Giacometti | Zendy; Oscar Cirioni | Zendy

Open Access

High Rate of Ceftobiprole Resistance among Clinical Methicillin-Resistant Staphylococcus aureus Isolates from a Hospital in Central Italy

Author(s) -

Gianluca Morroni,

Andrea Brenciani,

Lucia Brescini,

Simona Fioriti,

Serena Simoni,

Antonella Pocognoli,

Marina Mingoia,

Eleonora Giovanetti,

Francesco Barchiesi,

Andrea Giacometti,

Oscar Cirioni

Publication year - 2018

Publication title -

antimicrobial agents and chemotherapy

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.07

H-Index - 259

eISSN - 1070-6283

pISSN - 0066-4804

DOI - 10.1128/aac.01663-18

Subject(s) - staphylococcus aureus , penicillin binding proteins , microbiology and biotechnology , cephalosporin , penicillin , methicillin resistant staphylococcus aureus , antibacterial agent , antibiotics , biology , medicine , virology , bacteria , genetics

Ceftobiprole is a fifth-generation cephalosporin with activity against methicillin-resistantStaphylococcus aureus (MRSA). One-year surveillance at the Regional Hospital of Ancona (Italy) disclosed a 12% ceftobiprole resistance rate (12/102 isolates; MIC, ≥4 mg/liter).

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research